carnitine has been researched along with Epidermolysis Bullosa Dystrophica in 2 studies
Epidermolysis Bullosa Dystrophica: Form of epidermolysis bullosa characterized by atrophy of blistered areas, severe scarring, and nail changes. It is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms. All forms of dystrophic epidermolysis bullosa result from mutations in COLLAGEN TYPE VII, a major component fibrils of BASEMENT MEMBRANE and EPIDERMIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cunnington, PM | 1 |
| Addison, R | 1 |
| Sidwell, RU | 1 |
| Yates, R | 1 |
| Atherton, D | 1 |
1 review available for carnitine and Epidermolysis Bullosa Dystrophica
| Article | Year |
|---|---|
Dilated cardiomyopathy in dystrophic epidermolysis bullosa.
Topics: Biomarkers; Cardiomyopathy, Dilated; Carnitine; Child; Child, Preschool; Echocardiography; Epidermol | 2000 |
1 other study available for carnitine and Epidermolysis Bullosa Dystrophica
| Article | Year |
|---|---|
Dilated cardiomyopathy in dystrophic epidermolysis bullosa: a lethal complication of epidermolysis bullosa.
Topics: Anesthesia, General; Cardiomyopathy, Dilated; Carnitine; Echocardiography; Epidermolysis Bullosa Dys | 2002 |